These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 12971448

  • 1. Cessation of steroids in stable renal transplant patients: the Leuven experience.
    Maes BD, Claes K, Coosemans W, Evenpoel P, Kuypers D, Pirenne J, Vanrenterghem Y.
    Clin Transpl; 2002; ():181-9. PubMed ID: 12971448
    [Abstract] [Full Text] [Related]

  • 2. Successful steroid withdrawal after long-term administration in renal transplant patients.
    Amada N, Kikuchi H, Haga I, Fukumori T, Sato A, Sato T.
    Transplant Proc; 2009; 41(1):135-7. PubMed ID: 19249498
    [Abstract] [Full Text] [Related]

  • 3. Late corticosteroid withdrawal can be safely performed for kidney recipients with stable graft function under pathological confirmation.
    Harada H, Miura M, Ogawa Y, Seki T, Taniguchi A, Takenouchi T, Togashi M, Hirano T.
    Clin Transplant; 2006; 20 Suppl 15():26-32. PubMed ID: 16848872
    [Abstract] [Full Text] [Related]

  • 4. Benefits derivated from late steroid withdrawal in renal transplant recipients.
    Gavela E, Avila A, Sancho A, Kanter J, Beltrán S, Crespo JF, Pallardó LM.
    Transplant Proc; 2007 Sep; 39(7):2173-5. PubMed ID: 17889128
    [Abstract] [Full Text] [Related]

  • 5. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 6. Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications.
    Miozzari M, Ambühl PM.
    Nephrol Dial Transplant; 2004 Oct; 19(10):2615-21. PubMed ID: 15280521
    [Abstract] [Full Text] [Related]

  • 7. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
    Roberti I, Reisman L, Lieberman KV, Burrows L.
    Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
    [Abstract] [Full Text] [Related]

  • 8. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 9. Rapamycin at six years can exhibit normal renal function without proteinuria or neoplasia after renal transplantation. A single-center experience.
    Nungaray N, Arriola M, Gutierrez MJ, Oliva E, Hernández E, Gonzalez E, Andres A, Morales JM.
    Transplant Proc; 2005 Nov; 37(9):3727-8. PubMed ID: 16386519
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 11. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

  • 12. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

  • 13. Impact of the addition of maintenance steroids to a rapid steroid discontinuation immunosuppressive protocol following acute renal transplant rejection.
    Arora S, Marcus RJ, Dikkala S, Sureshkumar KK.
    Exp Clin Transplant; 2009 Dec; 7(4):233-6. PubMed ID: 20353373
    [Abstract] [Full Text] [Related]

  • 14. Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection.
    Oettl T, Zuliani E, Gaspert A, Hopfer H, Dickenmann M, Fehr T.
    Transplantation; 2010 Mar 27; 89(6):702-6. PubMed ID: 20010328
    [Abstract] [Full Text] [Related]

  • 15. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW.
    Clin Transpl; 2002 Mar 27; ():335-49. PubMed ID: 12971460
    [Abstract] [Full Text] [Related]

  • 16. Renal retransplantation: a retrospective monocentric study.
    Ott U, Busch M, Steiner T, Schubert J, Wolf G.
    Transplant Proc; 2008 Jun 27; 40(5):1345-8. PubMed ID: 18589102
    [Abstract] [Full Text] [Related]

  • 17. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M.
    Transplant Proc; 2005 Nov 27; 37(9):3738-42. PubMed ID: 16386523
    [Abstract] [Full Text] [Related]

  • 18. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R, Cinti P, Lai Q, Poli L, Berloco PB.
    Transpl Immunol; 2008 Nov 27; 20(1-2):3-5. PubMed ID: 18773959
    [Abstract] [Full Text] [Related]

  • 19. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P, Astellas Corticosteroid Withdrawal Study Group.
    Ann Surg; 2008 Oct 27; 248(4):564-77. PubMed ID: 18936569
    [Abstract] [Full Text] [Related]

  • 20. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
    Walker JK, Alloway RR, Roy-Chaudhury P, Mogilishetty G, Cardi MA, Weimert NA, Rike AH, First MR, Woodle ES.
    Transplantation; 2009 Feb 15; 87(3):408-14. PubMed ID: 19202447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.